Be part of the knowledge.™

Neurology and Neurosurgery

2550

LikeLikedUnlike

Episodes 1-15 of 762

Negative Symptoms in Schizophrenia: Identifying and Managing the Hidden Burden
On the Frontlines of Schizophrenia
Negative Symptoms in Schizophrenia: Identifying and Managing the Hidden Burden
- Brian P. McDonough, MD, FAAFP
  Peer
- Ahmed Makhlouf, MD
  Peer
Advancing Schizophrenia Care: When and How to Use Novel Therapies in Complex Patients
NeuroFrontiers
Advancing Schizophrenia Care: When and How to Use Novel Therapies in Complex Patients
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Ragy R. Girgis, MD, MS
  Peer
- Desiree Matthews, PMHNP-BC
  Peer
Using fMRI to Identify Early Alzheimer’s Disease Subgroups
NeuroFrontiers
Using fMRI to Identify Early Alzheimer’s Disease Subgroups
- Hamid Abuwarda, PhD, BS
  Peer
Evaluating AR1001: A Phase 3 Trial in Early Alzheimer’s Disease
NeuroFrontiers
Evaluating AR1001: A Phase 3 Trial in Early Alzheimer’s Disease
- Sharon Sha, MD, MS
  Peer
Understanding Schizophrenia: The Role of Neurotransmission and Inflammation
NeuroFrontiers
Understanding Schizophrenia: The Role of Neurotransmission and Inflammation
- Jeffrey A. Lieberman, MD
  Peer
Harnessing AI to Predict and Prevent Schizophrenia Relapse
NeuroFrontiers
Harnessing AI to Predict and Prevent Schizophrenia Relapse
- Matcheri S. Keshavan, MD
  Peer
advertisement
Engaging Patients and Caregivers in Schizophrenia: A Collaborative Care Approach
NeuroFrontiers
Engaging Patients and Caregivers in Schizophrenia: A Collaborative Care Approach
- Shelina Ramnarine, PhD
  Peer
- Apurva Bhatt, MD
  Peer
- Shannon Pagdon, BA
  Peer
Applying CBT for Psychosis in Schizophrenia Care: Strategies for Expanding Access
NeuroFrontiers
Applying CBT for Psychosis in Schizophrenia Care: Strategies for Expanding Access
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- David Kimhy, PhD
  Peer
Real-World Cases in Pediatric Low-Grade Glioma: Exploring Targeted Therapies
Project Oncology®
Real-World Cases in Pediatric Low-Grade Glioma: Exploring Targeted Therapies
- Alexandria May, PharmD, BCPS
  Peer
- Angela Waanders, MD, MPH, MS
  Peer
- Ashley S. Margol, MD, MS
  Peer
Improving Survival and Function in Pediatric TK2d with Nucleoside Therapy
Clinician's Roundtable
Improving Survival and Function in Pediatric TK2d with Nucleoside Therapy
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Caterina Garone, MD, PhD
  Peer
Uncovering the Disease Burden of Untreated Pediatric TK2 Deficiency
Clinician's Roundtable
Uncovering the Disease Burden of Untreated Pediatric TK2 Deficiency
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Cristina Domínguez González, MD, PhD
  Peer
Understanding the Caregiver Burden in TK2 Deficiency: New Insights from a Study
Clinician's Roundtable
Understanding the Caregiver Burden in TK2 Deficiency: New Insights from a Study
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Philip Yeske, PhD
  Peer
advertisement
Advancing gMG Care: Conversations with Clinicians at AANEM
NeuroFrontiers
Advancing gMG Care: Conversations with Clinicians at AANEM
- Marlene Mimi Maeusli, PhD
  Peer
- Michael Weiss, MD
  Peer
- Joshua Alpers, MD
  Peer
- James F. Howard, Jr, MD
  Peer
- Omar Sinno, MD, MBA
  Peer
- Rodrigo Rodriguez, MD
  Peer
- Sheetal Shroff, MD
  Peer
Personalizing Treatment for gMG: On the Ground at AANEM
NeuroFrontiers
Personalizing Treatment for gMG: On the Ground at AANEM
- Marlene Mimi Maeusli, PhD.
  Peer
- Rodrigo Rodriguez, MD
  Peer
- Sheetal Shroff, MD
  Peer
- Joshua Alpers, MD
  Peer
Evaluating Sabirnetug in Early Alzheimer’s: Targeting Soluble Aβ Oligomers
NeuroFrontiers
Evaluating Sabirnetug in Early Alzheimer’s: Targeting Soluble Aβ Oligomers

Program Chapters

Segment Chapters

Playlist:

Recommended